Latest Data For Edwards’ Sapien Suggest Steep Learning Curve For Doctors

Analysts are disappointed with the mortality data in European registries of Edwards Lifesciences' Sapien transcatheter aortic heart valve, but are optimistic that outcomes will improve in the U.S. trial as physicians get better at implanting the device